• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多能性畸胎瘤-胸腺体细胞杂种

Pluripotent teratocarcinoma-thymus somatic cell hybrids.

作者信息

Miller R A, Ruddle F H

出版信息

Cell. 1976 Sep;9(1):45-55. doi: 10.1016/0092-8674(76)90051-9.

DOI:10.1016/0092-8674(76)90051-9
PMID:61820
Abstract

We have produced a series of somatic cell hybrids by fusing pluripotent PCC4aza1 embryonal carcinoma ("teretocarcinoma") cells with thymocytes from young adult mice. When these hybrids form tumors in nu/nu or syngeneic mice, all the tumors contain a range of differentiated tissues, as well as embryonal carcinoma-like tissues. Some of the tumors produce alpha-fetoprotein. These results show that pluripotency in embryonal carcinoma cells need not to be abolished by the introduction of a complete diploid genome from a differentiated cell.

摘要

我们通过将多能性的PCC4aza1胚胎癌细胞(“畸胎癌”细胞)与成年幼鼠的胸腺细胞融合,制备了一系列体细胞杂种。当这些杂种在裸鼠或同基因小鼠中形成肿瘤时,所有肿瘤都包含一系列分化组织以及胚胎癌样组织。一些肿瘤会产生甲胎蛋白。这些结果表明,引入来自分化细胞的完整二倍体基因组不一定会消除胚胎癌细胞中的多能性。

相似文献

1
Pluripotent teratocarcinoma-thymus somatic cell hybrids.多能性畸胎瘤-胸腺体细胞杂种
Cell. 1976 Sep;9(1):45-55. doi: 10.1016/0092-8674(76)90051-9.
2
Hybrids between F9 nullipotent teratocarcinoma and thymus cells produce multidifferentiated tumors in mice.F9 全能性畸胎瘤细胞与胸腺细胞的杂交体在小鼠体内产生多分化肿瘤。
Dev Biol. 1983 Apr;96(2):331-6. doi: 10.1016/0012-1606(83)90170-7.
3
Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.小鼠畸胎瘤细胞与胸腺细胞杂交体的分化改变、无限生长潜力、致瘤性降低及嵌合潜力受抑制。
J Exp Pathol. 1984;1(2):103-33.
4
Supermelanotic hybrids between mouse teratocarcinoma and mouse melanoma cells.
Exp Cell Res. 1984 Oct;154(2):625-31. doi: 10.1016/0014-4827(84)90188-5.
5
Nullipotent teratocarcinoma cells acquire the pluripotency for differentiation by fusion with somatic cells.无效能畸胎瘤细胞通过与体细胞融合获得分化的多能性。
Differentiation. 1982;23(1):83-6. doi: 10.1111/j.1432-0436.1982.tb01269.x.
6
Properties of teratocarcinoma-thymus somatic cell hybrids.畸胎癌-胸腺体细胞杂种的特性。
Somatic Cell Genet. 1977 May;3(3):247-61. doi: 10.1007/BF01538744.
7
Antigen expression by somatic cell hybrids of a murine embryonal carcinoma cell with thymocytes and L cells.小鼠胚胎癌细胞与胸腺细胞和L细胞的体细胞杂种的抗原表达。
Somatic Cell Genet. 1980 Mar;6(2):271-84. doi: 10.1007/BF01538801.
8
Somatic cell hybrids between totipotent mouse teratocarcinoma and rat hepatoma cells.全能性小鼠畸胎瘤细胞与大鼠肝癌细胞之间的体细胞杂种。
J Cell Physiol. 1979 Oct;101(1):1-8. doi: 10.1002/jcp.1041010102.
9
Regulation of phenotype in somatic cell hybrids derived by fusion of teratocarcinoma cell lines with normal or tumor-derived mouse cells.通过将畸胎瘤细胞系与正常或肿瘤来源的小鼠细胞融合产生的体细胞杂种中表型的调控。
Dev Biol. 1981 Jan 30;81(2):245-54. doi: 10.1016/0012-1606(81)90288-8.
10
Apparent species restriction in the isolation of proliferating embryonal carcinoma cell hybrids.
Cell Biol Int Rep. 1983 Jun;7(6):447-54. doi: 10.1016/0309-1651(83)90134-0.

引用本文的文献

1
Human iPS Cells for Clinical Applications and Cellular Products.用于临床应用和细胞产品的人类诱导多能干细胞。
Handb Exp Pharmacol. 2023;281:3-27. doi: 10.1007/164_2023_643.
2
Cell pairing for biological analysis in microfluidic devices.用于微流控设备中生物分析的细胞配对
Biomicrofluidics. 2022 Nov 8;16(6):061501. doi: 10.1063/5.0095828. eCollection 2022 Dec.
3
Embryonic Environmental Niche Reprograms Somatic Cells to Express Pluripotency Markers and Participate in Adult Chimaeras.胚胎环境生态位将体细胞重编程为表达多能性标志物并参与成体嵌合体。
Cells. 2021 Feb 25;10(3):490. doi: 10.3390/cells10030490.
4
All roads lead to Rome: the many ways to pluripotency.殊途同归:多能性的多种途径。
J Assist Reprod Genet. 2020 May;37(5):1029-1036. doi: 10.1007/s10815-020-01744-3. Epub 2020 Mar 20.
5
The march of pluripotent stem cells in cardiovascular regenerative medicine.多能干细胞在心血管再生医学中的进展。
Stem Cell Res Ther. 2018 Jul 27;9(1):201. doi: 10.1186/s13287-018-0947-5.
6
Pluripotent stem cells: induction and self-renewal.多能干细胞:诱导与自我更新。
Philos Trans R Soc Lond B Biol Sci. 2018 Jul 5;373(1750). doi: 10.1098/rstb.2017.0213.
7
Tetraploid embryonic stem cells can contribute to the development of chimeric fetuses and chimeric extraembryonic tissues.四倍体胚胎干细胞可以参与嵌合体胎儿和嵌合体胚胎外组织的发育。
Sci Rep. 2017 Jun 8;7(1):3030. doi: 10.1038/s41598-017-02783-0.
8
Single-cell RNA-seq reveals activation of unique gene groups as a consequence of stem cell-parenchymal cell fusion.单细胞RNA测序揭示了干细胞与实质细胞融合导致独特基因组激活的现象。
Sci Rep. 2016 Mar 21;6:23270. doi: 10.1038/srep23270.
9
The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders.细胞身份重编程治疗与衰老相关的神经退行性疾病的治疗潜力。
Prog Neurobiol. 2017 Oct;157:212-229. doi: 10.1016/j.pneurobio.2016.01.006. Epub 2016 Feb 1.
10
Induced Pluripotency and Epigenetic Reprogramming.诱导多能性与表观遗传重编程
Cold Spring Harb Perspect Biol. 2015 Dec 1;7(12):a019448. doi: 10.1101/cshperspect.a019448.